ADDvise Group

ADDvise recruits Oliver Humlen as new CFO and member of the executive management team. Oliver has more than a decade of experience from investment banking. He joins ADDvise from Pareto Securities where he has been working within Debt Capital Markets for the past nine years, of which six as Partner. Prior to that, he worked with Mergers and Acquisitions at Barclays in London. Oliver has a BSc in Business Management from King’s College, London. He will commence his employment no later than September 18, 2023.

-          We are excited about this recruitment which will strengthen our capabilities with capital markets, financing, and M&A. I have had the benefit of working with Oliver on several capital market transactions and his experience and competence will be a great addition to the group. Oliver is well acquainted with ADDvise which will facilitate a smooth transition, says CEO Rikard Akhtarzand.

The current CFO, Sebastian Robson, is leaving ADDvise by mutual agreement.

-          I would like to take this opportunity to thank Sebastian for his commendable work, which has made a significant impact on ADDvise's growth journey, says Rikard Akhtarzand.

To further strengthen ADDvise’s finance department, current Corporate Controller, Johan Irwe, is appointed VP Finance effective today. Johan will report directly to the CFO.

For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.